The contribution of matrix metalloproteinases and their inhibitors to the development, progression, and rupture of abdominal aortic aneurysms
Abdominal aortic aneurysms (AAAs) account for up to 8% of deaths in men aged 65 years and over and 2.2% of women. Patients with AAAs often have atherosclerosis, and intimal atherosclerosis is generally present in AAAs. Accordingly, AAAs are considered a form of atherosclerosis and are frequently ref...
Main Authors: | Georgia Atkinson, Rosaria Bianco, Karina Di Gregoli, Jason L. Johnson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1248561/full |
Similar Items
-
Role of Matrix Metalloproteinases and Their Inhibitors in Locally Invasive Papillary Thyroid Cancer
by: Irena Ivković, et al.
Published: (2022-12-01) -
Smooth Muscle Heterogeneity and Plasticity in Health and Aortic Aneurysmal Disease
by: Yunwen Hu, et al.
Published: (2023-07-01) -
Metalloproteinases in Endometrial Cancer—Are They Worth Measuring?
by: Kaja Michalczyk, et al.
Published: (2021-11-01) -
The Role of Matrix Metalloproteinases in Thoracic Aortic Disease: Are They Indicators for the Pathogenesis of Dissections?
by: Marc Irqsusi, et al.
Published: (2024-03-01) -
The effects of statin therapy on aneurysm size, growth rate, and matrix metalloproteinases-9 levels in patients with aortic aneurysm: a systematic review and meta-analysis
by: Ketut Angga Aditya Putra Pramana, et al.
Published: (2023-10-01)